The focus and application of my research program is centered on the intersection of pharmaceutical health services, pharmacoepidemiology, and implementation science. My research approach emphasizes multi-disciplinary and collaborative research strategies encompassing interventional, observational, and mixed methods across a variety of therapeutic areas. Specifically, my current research has three main areas of focus:
1) use of large data sets, data mining techniques, and comparative effectiveness research to predict and evaluate outcomes of acute and chronic medications,
2) implementation and evaluation of pharmacist care services to improve patient safety and care quality,
3) optimizing chronic disease management and treatment adherence through cost-effective approaches.
Member of Team Alice, an interprofessional initiative to protect older adults from medication related harm.
Education and Training:
PhD, Epidemiology, University at Buffalo School of Public Health and Health Professions (2018)
PGY-2 Infectious Diseases Residency, Universtiy of Houston College of Pharmacy (2013)
PGY-1 Pharmacy Practice Residency, University of Toledo Medical Center (2012)
PharmD, Pharmacy, University at Buffalo School of Pharmacy and Pharmaceutical Sciences (2011)
BS, Chemistry, Binghamton University (2007)
Employment:
Assistant Professor, Pharmacy Practice, University at Buffalo, School of Pharmacy (2018-present)
Clinical Assistant Professor, Pharmacy Practice, University at Buffalo, School of Pharmacy (2014–2018)
Awards and Honors:
Saxon Graham Award for Academic Excellence in Epidemiology, School of Public Health and Health Professions, University at Buffalo (2019)
Faculty Research Award, Department of Pharmacy Practice, UB School of Pharmacy and Pharmaceutical Sciences (2019)
Presentation Merit Award Semifinalist, Annual Meeting of the American Pharmacists Association (2019)
Best Research Poster Award Finalist, 24th Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (2019)
Holger Schunemann Award for Graduate Student Research, Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo (2018)
Delta Omega Honorary Society in Public Health, University at Buffalo (2018)
Best Poster Finalist, 22nd Annual International Meeting of the International Society of Pharmacoeconomics and Outcomes Research (2017)
Infectious Diseases Society of America Travel Grant (2016)
Who's Who Among Students in American Universities and Colleges (2015)
International Society of Pharmacoeconomics and Outcomes Research Travel Grant (2015)
Infectious Diseases Society of America Fellow Travel Grant (2014)
Making a Difference in Infectious Disease Pharmacotherapy (MAD-ID) Resident Travel Grant (2013)
Shining Star Award, University of Toledo (2011)
Mylan Pharmaceutical Inc., Excellence in Pharmacy Award (2011)
American Assoication of Colleges of Pharmacy - Wal Mart Scholarship (2010)
Grants and Sponsored Research:
March 2023–February 2024 A Pilot Pharmacist-to-pharmacist Hand-off Intervention During Transitions of Care American Association of Colleges of Pharmacy Role: Co-Investigator $7,500
August 2020–July 2021 Planning for NIA R21/R33 Grant- Patient Driven Deprescribing to Enhance Successful Aging US Deprescribing Research Network Role: Co-Investigator $60,000
July 2020–June 2021 Comparison of triple therapy with apixaban vs. rivaroxabn American College of Clinical Pharmacy Cardiology PRN Role: Co-Investigator
July 2019–June 2021 Implementation Research to Improve Medication Management in COPD NIH/National Heart, Lung, and Blood Institute Loan Repayment Award, Clinical Research Role: Principal Investigator
July 2019–June 2021 Impact of an integrated pharmacist and primary care collaborative transitions of care program on clinical and economic outcomes among high risk patients ASHP Foundation Role: Principal Investigator $77,618
May 2019–April 2021 Development and implementation of a chronic obstructive pulmonary disease care transition intervention integrating pharmacists onto the care team. NIH/National Heart, Lung, and Blood Institute (1K12HL138052-01) Role: Principal Investigator
May 2019–April 2021 Community-Based Participatory Research for Reducing Medication Harm among Retirees Retirement Research Foundation Role: Co-Investigator $200,000
January 2020–January 2021 Impact and feasibility of establishing a community health worker program within community pharmacy settings Community Pharmacy Foundation Role: Principal Investigator
August 2019–July 2020 The Deprescribing Network of Western New York for Successful Aging UB Seeds for Innovation in Successful Aging Role: Co-Investigator $30,000
July 2018–June 2020 Pain medication prescription following treatment for alcohol use disorder National Institute on Alcoholism and Alcohol Abuse Role: Co-Investigator $386,013
September 2017–September 2019 Optimizing Pain Management and Opioid Safety: A Community Pharmacy Intervention to Prevent Opioid Adverse Drug Events Centers for Medicare and Medicaid Services Role: Co-Investigator
July 2017–June 2019 Clinical Epidemiology in Chronic Obstructive Pulmonary Disease NIH/National Heart, Lung, and Blood Institute Loan Repayment Award, Clinical Research Role: Principal Investigator
February 2018–April 2019 A Pilot Study to Evaluate Objective Assessment Tools to Improve Medication Management in Chronic Obstructive Pulmonary Disease Buffalo Translational Consortium Mentored Career Development Award Role: Principal Investigator
February 2017–June 2018 Proton pump Inhibitors and the Risk of Acute Kidney Disease and Chronic Kidney Disease in a Medicaid Population University at Buffalo School of Pharmacy and Pharmaceutical Sciences Seed Grant Role: Principal Investigator
July 2015–June 2017 Multi-Center Characterization of the Treatment of Candiduria Astellas Pharmaceuticals Investigator Initiated Research Role: Principal Investigator
January 2016–December 2016 Development of a Clinical Risk Score to Identify 30-day Rehospitalization among Patients on Outpatient Intravenous Antibiotic Therapy Research for Health in Erie County, Inc. Role: Principal Investigator
Slazak EM, Cardinal CM, Will S, Clark C, Daly CJ, Jacobs DM. Pharmacist-led transition of care services in primary care settings: opportunities, experiences, and challenges. Journal of the American Pharmacists Association. 2020; 60.
Jacobs DM, Holsen M, Chen S, Fusco NM, Hassinger AB. The Utility of Procalcitonin to Support Clinical Decision Making in Critically Ill Pediatric Patients. Open Forum Infectious Diseases. 2016; 3.
Loan Repayment Program Ambassador, Division of Loan Repayment, National Institutes of Health (2018–present)
International Society of Pharmacoeconomics and Outcomes Research (2016–present)
Society of Infectious Disease Pharmacists (2012–present)
American College of Clinical Pharmacy (2011–present)
American Association of Colleges of Pharmacy (2010–present)
Presentations:
"A systematic review on the impact of antifungal stewardship interventions in the United States" Annual meeting of the American College of Clinical Pharmacy (2018)
"Adjuvant β-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does β-lactam class matter." Annual Meeting of the Infectious Diseases Society of America (2018)
"Proton pump inhibitors and risk of acute and chronic kidney disease: a retrospective cohort study" Annual meeting of the American College of Clinical Pharmacy (2018)
"Characterization of candiduria treatment: a multi-institutional study." 57th Interscience Conference on Antimicrobial Agents and Chemotherapy (2017)
"Risk factors for healthcare utilization among patients discharged on outpatient parenteral antimicrobial therapy." 57th Interscience Conference on Antimicrobial Agents and Chemotherapy (ASM Microbe), (2017)
"Changing Epidemiology of Pneumococcal Meningitis in the United States, 2008-2013." Annual meeting of the International Society of Pharmacoeconomics and Outcomes Research (2017)
"The utility of procalcitonin to support clinical decision making in critically ill pediatric patients." 54th Annual Meeting of the Infectious Diseases Society of America (2016)
"Incidence and outcomes of S. aureus pneumonia among hospitalized patients in the United States, 2009 – 2012." International Society of Pharmacoeconomics and Outcomes Research (2016)
"Early beta-lactam therapy combined with standard therapy for methicillin-resistant S. aureus bloodstream infections compared to standard therapy alone: a multicenter, restrospective, propensity-matched analysis." 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, (2015)
"Shifts in incidence and mortality of ESKAPE septicemia among US hospitalized patients from 2008-2012" 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (2015)
"Triple antibiotic combinations for the treatment of carbapenemase-producing Enterobacteriaceae (CPE): an outcomes based systematic review." 55th Interscience Conference on Antimicrobial Agents and Chemotherapy, (2015)
"Current attitudes and perceptions of dual PharmD/MBA degree program students: a qualitative analysis." Annual meeting of the American Association of Colleges of Pharmacy (2015)
"Impact of a master of business administration (MBA) degree on the career of a pharmacists." Annual meeting of the American Association of Colleges of Pharmacy (2015)
"Clinical comparison of full course intravenous or abbreviated oral antibiotics in hospitalized patients with MRSA skin and soft tissue infections." Annual meeting of the International Society of Pharmacoeconomics and Outcomes Research, (2015)
"Evaluation of bleeding outcomes linked to new oral anticoagulants: a review of the FDA adverse event reporting system." Annual meeting of the International Society of Pharmacoeconomics and Outcomes Research (2015)
"Analysis of an enhanced medication letter initiative within a Medicaid retrospective drug utilization program" Annual meeting of the American Pharmacists Association (2015)
"Effectiveness of a mailed letter intervention to address potentially inappropriate psychiatric medication use with a Medicaid fee-for service population" Annual meeting of the American Pharmacists Association (2015)
"Antibiotic polytherapy against multidrug-resistant, KPC-2 producing Enterobacter infections: case series and systematic review" Annual meeting of the American College of Clinical Pharmacy (2014)
"Comparison of weight and metabolic profiles in patients treated with an oral mimetic of the Roux-en-Y gastric bypass effect" Annual meeting of the American Gastroenterological Association at Digestive Disease Week (2014)
"Host factors for Candida colonization in critically ill patients" 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (2013)